Related Experiment Videos
Intensive insulin therapy: euglycemia with a price tag
1Department of Medicine, Mount Sinai School of Medicine (CUNY), New York 10029.
The Mount Sinai Journal of Medicine, New York
|September 1, 1991
Summary
Intensive insulin therapy aims to lower blood glucose, potentially preventing diabetic complications. However, preventing hypoglycemia remains the top priority for patients undergoing this treatment.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Diabetes Mellitus Research
Background:
- The benefits of intensive insulin therapy for microvascular complications in diabetes are under investigation.
- Hyperglycemia correlates with long-term diabetic complications, but the specific glycemic threshold for risk remains unknown.
Purpose of the Study:
- To investigate the benefits of lowering blood glucose levels through intensive insulin therapy.
- To determine the glycemic level at which the risk of long-term diabetic complications occurs.
Main Methods:
- Review of existing studies correlating hyperglycemia and diabetic complications.
- Anticipation of results from the Diabetes Control and Complications Trial.
Main Results:
- A correlation between hyperglycemia and the risk of long-term diabetic complications is established.
- The precise glycemic threshold for increased risk has not yet been definitively identified.
Conclusions:
- The Diabetes Control and Complications Trial is expected to clarify the risks associated with specific glycemic levels.
- Patient education on prioritizing hypoglycemia prevention is crucial for those on intensive insulin regimens.